| 2022 |
Investigating the efficacy of baricitinib in new onset type 1 diabetes mellitus (BANDIT)-study protocol for a phase 2, randomized, placebo controlled trial
Trials |
Waibel, M Thomas, HE Wentworth, JM Couper, JJ MacIsaac, RJ Cameron, FJ So, M Krishnamurthy, B Doyle, MC Kay, TW |